UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 26, 2009
Shire plc
________________________________________________________________________________
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands
________________________________________________________________________________
(State or other jurisdiction of incorporation)
0-29630 98-0601486
(Commission File Number) (IRS Employer Identification No.)
5 Riverwalk, Citywest Business Campus, Dublin
24, Republic of Ireland
________________________________________________________________________________
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code +353 1 429 7700
________________________________________________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))
Item 8.01. Other Events
Shire plc has issued the press release attached hereto as Exhibit 99.01 which is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits. The following exhibit is filed herewith:
99.01 Press Release dated May 26, 2009
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SHIRE PLC | ||
| By: | /s/ A C Russell | |
| Name: Angus Russell | ||
| Title: Chief Executive Officer | ||
Dated: May 26, 2009
| EXHIBIT INDEX | |
| Number | Description |
| 99.01 | Press Release dated May 26, 2009 |
Exhibit 99.01
| Press Release |  |
| www.shire.com |
BLOCK LISTING SIX MONTHLY RETURN
May 26, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY)
Name of applicant: | Shire plc | |||
| Name of scheme: | 1996 Executive Share Option Scheme | |||
| Period of return: | From: | 23 November 2008 | To: | 22 May 2009 |
| Balance of unallotted securities under scheme(s) from previous return: | 82,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | Nil | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 82,000 | |||
Name of applicant: | Shire plc | |||
| Name of scheme: | 2000 Executive Share Option Scheme | |||
| Period of return: | From: | 23 November 2008 | To: | 22 May 2009 |
| Balance of unallotted securities under scheme(s) from previous return: | 5,900,615 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 203,583 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,697,032 | |||
Registered in Jersey, No. 99854, 22 Grenville Street, St. Helier, Jersey JE4 8PX
Name of applicant: | Shire plc | |||
| Name of scheme: | Shire Sharesave Scheme | |||
| Period of return: | From: | 23 November 2008 | To: | 22 May 2009 |
| Balance of unallotted securities under scheme(s) from previous return: | 76,685 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 44,344 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 32,341 | |||
Name of applicant: | Shire plc | |||
| Name of scheme: | Biochem Pharma Stock Option Plan | |||
| Period of return: | From: | 23 November 2008 | To: | 22 May 2009 |
| Balance of unallotted securities under scheme(s) from previous return: | 14,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 4,778 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 9,222 | |||
| Name of contact: | Tony Guthrie, Deputy Company Secretary |
| Address of contact: | Hampshire International Business Park Basingstoke, Hampshire, RG24 8EP |
| Telephone number of contact: | 01256 894746 |
For further information please contact:
| Investor Relations | Cléa Rosenfeld (Rest of the World) | +44 1256 894 160 |
| Eric Rojas (North America) | +1 617 551 9715 |
Notes to editors
SHIRE PLC
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company’s website: www.shire.com.